Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2017

May 2, 2017

5262_dirs_2017-05-02_d43ad7f7-3ba5-4205-99c1-c5cd685d573f.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9177D

GlaxoSmithKline PLC

02 May 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

1. Details of PDMR/person closely associated with them ('PCA')
a) Name Ms C Thomas
b) Position/status SVP, Human Resources
c) Initial notification/

amendment
Initial Notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GlaxoSmithKline plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial  instrument Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882
b) Nature of the transaction The exercise of a nil-cost option over Ordinary Shares granted on 20 March 2014 and, as previously announced, was adjusted for performance and vested on 20 March 2017 under the Company's 2009 Deferred Annual Bonus Plan- Matching Award associated with a post-tax bonus deferral.
c) Price(s) and

volume(s)
Price(s) Volume(s)
£0.0000 989
d) Aggregated information n/a single transaction
Aggregated volume Price
e) Date of the transaction 2017-04-28
f) Place of the transaction n/a
1. Details of PDMR/person closely associated with them ('PCA')
a) Name Ms C Thomas
b) Position/status SVP, Human Resources
c) Initial notification/

amendment
Initial Notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GlaxoSmithKline plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial  instrument Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882
b) Nature of the transaction The sale of Ordinary Shares to meet tax liabilities on a nil-cost option over Ordinary Shares exercised on 28 April 2017 under the Company's Deferred Annual Bonus Plan - Matching Award associated with a post-tax bonus deferral.
c) Price(s) and

volume(s)
Price(s) Volume(s)
£15.5450 467
d) Aggregated information n/a single transaction
Aggregated volume Price
e) Date of the transaction 2017-04-28
f) Place of the transaction London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLLFBDEFBBBF